Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia

Manju MamtaniHemant Kulkarni


It is being increasingly recognized that a majority of the countries in the thalassemia-belt need a cost-effective screening program as the first step towards control of thalassemia. Although the naked eye single tube red cell osmotic fragility test (NESTROFT) has been considered to be a very effective screening tool for beta-thalassemia trait, assessment of its diagnostic performance has been affected with the reference test- and verification-bias. Here, we set out to provide estimates of sensitivity and specificity of NESTROFT corrected for these potential biases. We conducted a cross-sectional diagnostic test evaluation study using data from 1563 subjects from Central India with a high prevalence of beta-thalassemia. We used latent class modelling after ensuring its validity to account for the reference test bias and global sensitivity analysis to control the verification bias. We also compared the results of latent class modelling with those of five discriminant indexes. We observed that across a range of cut-offs for the mean corpuscular volume (MCV) and the hemoglobin A2 (HbA2) concentration the average sensitivity and specificity of NESTROFT obtained from latent class modelling was 99.8 and 83.7%, respectively. These est...Continue Reading


Mar 26, 1977·Lancet·I Shine, S Lal
Oct 26, 1978·The New England Journal of Medicine·D F Ransohoff, A R Feinstein
Apr 14, 1973·Lancet·P C Srivastava, J M Bevington
Jun 30, 1973·Lancet·J M EnglandP M Fraser
Aug 1, 1981·Journal of Medical Genetics·C A KattamisS Pootrakul
Jan 1, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J Bernstein
Oct 23, 1997·Statistics in Medicine·V L Torrance-Rynard, S D Walter
Feb 26, 1998·Journal of Tropical Pediatrics·S GomberN Madan
Apr 17, 1999·Scandinavian Journal of Clinical and Laboratory Investigation·E J Harthoorn-LasthuizenM M Langenhuijsen
Jan 5, 2001·Clinical Chemistry and Laboratory Medicine : CCLM·A MoscaG Ivaldi
Feb 13, 2002·Indian Journal of Pediatrics·D ViswanathR Shah
Nov 8, 2002·Pediatrics International : Official Journal of the Japan Pediatric Society·Aysin DemirAbdurrahman Kara
Aug 27, 2003·Statistics in Medicine·Andrzej S Kosinski, Huiman X Barnhart
Oct 25, 2003·Science·David J Weatherall
Feb 6, 2004·Annals of Internal Medicine·Penny WhitingJos Kleijnen
Jul 22, 2004·Journal of Paediatrics and Child Health·N D NguyenK J Gaskin
Aug 25, 2004·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Supatra SirichotiyakulTheera Tongsong
Oct 14, 2004·Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology·Yohan RobinsonDieter Böning
Jan 13, 2005·Journal of Clinical Laboratory Analysis·M Shyla RavindranS P Dandekar
Jun 28, 2005·American Journal of Hematology·Jason ChowBarbara J Bain
Jun 29, 2005·American Journal of Clinical Pathology·Robert Van KirkJames D Hoyer
Feb 20, 2014·Journal of Clinical and Diagnostic Research : JCDR·Sanjay PiplaniJasmine Bawa


Jul 17, 2010·International Journal of Laboratory Hematology·Manju MamtaniHemant Kulkarni
Dec 19, 2014·British Journal of Haematology·Bridget S PenmanDavid J Weatherall
Jun 18, 2009·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Supada KhonyoungKate Grudpan

Related Concepts

Prevalence Studies
Mean Corpuscular Hemoglobin Concentration Determination
False Negative Reactions
Hemoglobin A2
Heterozygote Detection
Osmotic Fragility Test
Truncation Biases
Likelihood Functions
Thalassemia Minor

Related Feeds


Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

© 2021 Meta ULC. All rights reserved